Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domperidone vs Alginic Acid Add-on to Omeprazole in SSc-GERD
NCT01878526Phase 3Completed
- Sponsor
- Khon Kaen University
- Start
- Jun 2013
- Primary completion
- Aug 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing Omeprazole + Alginic Acid with Omeprazole + Domperidone (2 arms). Primary endpoints: Changing Severity of Heart Burn of SSc Related Omeprazole Resistant GERD Evaluated by Visual Analogue Score (VAS) at 8 weeks and Changing of the Severity of Regurgitation at 8 weeks. Started Jun 2013; status: completed.
02
Drugs
domperidonealginic acid
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01878526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878526.